Literature DB >> 11680889

Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electrophoresis approach prior to mass spectrometry.

P Davidsson1, L Paulson, C Hesse, K Blennow, C L Nilsson.   

Abstract

A preparative proteomic approach, involving liquid phase isoelectric focusing (IEF) in combination with one-dimensional electrophoresis and electroelution followed by mass spectrometry and database searches, was found to be an important tool for identifying low-abundant proteins (microgram/L) in human cerebrospinal fluid (CSF) and membrane proteins in human frontal cortex. Several neuron-related proteins, such as amyloid precursor-like protein, chromogranins A and B, glial fibrillary acid protein, beta-trace, transthyretin, ubiquitin, and cystatin C, were identified in CSF. Several types of proteins were also characterized from a detergent-solubilized human frontal cortex homogenate including membrane proteins such as synaptophysin, syntaxin and Na+/K+ ATPase. One-third of the identified proteins have not previously been identified in human CSF or human frontal cortex using proteomic techniques. The absence of these proteins in two-dimensional electrophoresis maps might be due to insufficient amounts or low solubility. The advantages of using preparative liquid phase electrophoretic separations for identifying proteins from complex biological mixtures are speed of analysis, high loadability in the IEF separation, nondiscrimination of membrane proteins or low abundance proteins, yielding sufficient amounts for characterization by mass spectrometry. The use of this strategy in proteome studies of CSF/brain tissue is expected to offer new perspectives in studies of the pathology of neurodegenerative diseases, and reveal new potential markers for brain disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11680889     DOI: 10.1002/1615-9861(200103)1:3<444::AID-PROT444>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  9 in total

Review 1.  Prospects of modeling poststroke epileptogenesis.

Authors:  Doodipala Samba Reddy; Aamir Bhimani; Ramkumar Kuruba; Min Jung Park; Farida Sohrabji
Journal:  J Neurosci Res       Date:  2016-07-25       Impact factor: 4.164

Review 2.  Proteomics of gliomas: initial biomarker discovery and evolution of technology.

Authors:  Juliya Kalinina; Junmin Peng; James C Ritchie; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2011-09       Impact factor: 12.300

3.  Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer's disease patients and healthy individuals.

Authors:  Carina Sihlbom; Pia Davidsson; Magnus Sjögren; Lars-Olof Wahlund; Carol L Nilsson
Journal:  Neurochem Res       Date:  2008-02-21       Impact factor: 3.996

4.  Cerebrospinal fluid biomarkers for dementia with lewy bodies.

Authors:  Elizabeta B Mukaetova-Ladinska; Rachael Monteith; Elaine K Perry
Journal:  Int J Alzheimers Dis       Date:  2010-10-17

5.  Cobalamin (vitamin B12)-deficiency-induced changes in the proteome of rat cerebrospinal fluid.

Authors:  Elisabetta Gianazza; Daniela Veber; Ivano Eberini; Francesca R Buccellato; Elena Mutti; Luigi Sironi; Giuseppe Scalabrino
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

6.  Sensitivity and specificity of decreased CSF asialotransferrin for eIF2B-related disorder.

Authors:  A Vanderver; Y Hathout; J Maletkovic; E S Gordon; M Mintz; M Timmons; E P Hoffman; L Horzinski; F Niel; A Fogli; O Boespflug-Tanguy; R Schiffmann
Journal:  Neurology       Date:  2008-06-03       Impact factor: 9.910

7.  Altered CSF Proteomic Profiling of Paediatric Acute Lymphocytic Leukemia Patients with CNS Infiltration.

Authors:  Fei Mo; Xuelei Ma; Xiaobei Liu; Ruofan Zhou; Yunuo Zhao; Hui Zhou
Journal:  J Oncol       Date:  2019-05-02       Impact factor: 4.375

8.  Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment.

Authors:  Debjani Guha; David R Lorenz; Vikas Misra; Sukrutha Chettimada; Susan Morgello; Dana Gabuzda
Journal:  J Neuroinflammation       Date:  2019-12-05       Impact factor: 8.322

9.  The proteome of human brain microdialysate.

Authors:  Martin H Maurer; Christian Berger; Margit Wolf; Carsten D Fütterer; Robert E Feldmann; Stefan Schwab; Wolfgang Kuschinsky
Journal:  Proteome Sci       Date:  2003-12-14       Impact factor: 2.480

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.